Ohtsuka M, Roussel M F, Sherr C J, Downing J R
Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105.
Mol Cell Biol. 1990 Apr;10(4):1664-71. doi: 10.1128/mcb.10.4.1664-1671.1990.
Ligand-induced tyrosine phosphorylation of the human colony-stimulating factor 1 receptor (CSF-1R) could involve either an intra- or intermolecular mechanism. We therefore examined the ability of a CSF-1R carboxy-terminal truncation mutant to phosphorylate a kinase-defective receptor, CSF-1R[met 616], that contains a methionine-for-lysine substitution at its ATP-binding site. By using an antipeptide serum that specifically reacts with epitopes deleted from the enzymatically competent truncation mutant, cross-phosphorylation of CSF-1R[met 616] on tyrosine was demonstrated, both in immune-complex kinase reactions and in intact cells stimulated with CSF-1. Both in vitro and in vivo, CSF-1R[met 616] was phosphorylated on tryptic peptides identical to those derived from wild-type CSF-1R, suggesting that receptor phosphorylation on tyrosine can proceed via an intermolecular interaction between receptor monomers. When expressed alone, CSF-1R[met 616] did not undergo ligand-induced down modulation, but its phosphorylation in cells coexpressing the kinase-active truncation mutant accelerated its degradation.
配体诱导的人集落刺激因子1受体(CSF-1R)的酪氨酸磷酸化可能涉及分子内或分子间机制。因此,我们检测了CSF-1R羧基末端截短突变体磷酸化激酶缺陷型受体CSF-1R[met 616]的能力,该受体在其ATP结合位点含有甲硫氨酸替代赖氨酸的突变。通过使用与酶活性截短突变体中缺失的表位特异性反应的抗肽血清,在免疫复合物激酶反应和用CSF-1刺激的完整细胞中均证实了CSF-1R[met 616]酪氨酸的交叉磷酸化。在体外和体内,CSF-1R[met 616]在与野生型CSF-1R相同的胰蛋白酶肽上被磷酸化,这表明受体酪氨酸磷酸化可通过受体单体之间的分子间相互作用进行。当单独表达时,CSF-1R[met 616]不会发生配体诱导的下调,但其在共表达激酶活性截短突变体的细胞中的磷酸化加速了其降解。